Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Prophylactic TxA administration in patients undergoing major gastrointestinal surgery reduces
the incidence of delirium after surgery when compared with placebo. The unifying hypothesis
is that systemic and neuro-inflammation lead to neuronal injury and resultant postoperative
delirium.